Home Newsletters Neural Cell News Concurrent Targeting of MAP3K3 and BRD4 by miR-3140-3p Overcomes Acquired Resistance to...

Concurrent Targeting of MAP3K3 and BRD4 by miR-3140-3p Overcomes Acquired Resistance to BET Inhibitors in Neuroblastoma Cells

0
Investigators demonstrated that miR-3140-3p suppresses tumor cell growth in MYCN-amplified NB by downregulating MYCN and MYC through BRD4 suppression.
[Molecular Therapy-Nucleic Acids]
7753456 {7753456:3PF2TEA3} apa 50 1 162129 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-3198b5319e619129738f84c905cdc462%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%223PF2TEA3%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELiu%2C%20C.%2C%20Gen%2C%20Y.%2C%20Tanimoto%2C%20K.%2C%20Muramatsu%2C%20T.%2C%20Inoue%2C%20J.%2C%20%26amp%3B%20Inazawa%2C%20J.%20%282021%29.%20Concurrent%20targeting%20of%20MAP3K3%20and%20BRD4%20by%20miR-3140-3p%20overcomes%20acquired%20resistance%20to%20BET%20inhibitors%20in%20neuroblastoma%20cells.%20%3Ci%3EMolecular%20Therapy%20-%20Nucleic%20Acids%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.omtn.2021.05.001%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.omtn.2021.05.001%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3D3PF2TEA3%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Concurrent%20targeting%20of%20MAP3K3%20and%20BRD4%20by%20miR-3140-3p%20overcomes%20acquired%20resistance%20to%20BET%20inhibitors%20in%20neuroblastoma%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuyuki%22%2C%22lastName%22%3A%22Gen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kousuke%22%2C%22lastName%22%3A%22Tanimoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tomoki%22%2C%22lastName%22%3A%22Muramatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jun%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johji%22%2C%22lastName%22%3A%22Inazawa%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222021-05-10%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.omtn.2021.05.001%22%2C%22ISSN%22%3A%222162-2531%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cell.com%5C%2Fmolecular-therapy-family%5C%2Fnucleic-acids%5C%2Fabstract%5C%2FS2162-2531%2821%2900117-7%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22TUURQW3H%22%5D%2C%22dateModified%22%3A%222021-05-11T22%3A36%3A05Z%22%7D%7D%5D%7D
Liu, C., Gen, Y., Tanimoto, K., Muramatsu, T., Inoue, J., & Inazawa, J. (2021). Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells. Molecular Therapy - Nucleic Acids, 0(0). https://doi.org/10.1016/j.omtn.2021.05.001 Cite
AbstractGraphical Abstract
Exit mobile version